Armata Pharmaceuticals (AMEX:ARMP) 公司報告季度每股虧損$(0.23)，比分析師一致預期的$(0.35)高出34.29%。與去年同期每股虧損$(0.55)相比，提升了58.18%。公司報告季度銷售額爲$1.24百萬，低於分析師一致預期的$1.56百萬，減少20.83%。與去年同期銷售額$1.53百萬相比，下降了19.18%。

以上內容來自Benzinga Earnings專欄，原文如下：

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.35) by 34.29 percent. This is a 58.18 percent increase over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $1.24 million which missed the analyst consensus estimate of $1.56 million by 20.83 percent. This is a 19.18 percent decrease over sales of $1.53 million the same period last year.